Passive targeting of nanoparticles to cancer: A comprehensive review of the literature

  • Authors:
    • Remon Bazak
    • Mohamad Houri
    • Samar El Achy
    • Wael Hussein
    • Tamer Refaat
  • View Affiliations

  • Published online on: July 23, 2014     https://doi.org/10.3892/mco.2014.356
  • Pages: 904-908
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cancer remains the one of the most common causes of mortality in humans; thus, cancer treatment is currently a major focus of investigation. Researchers worldwide have been searching for the optimal treatment (the ‘magic bullet’) that will selectively target cancer, without afflicting significant morbidity. Recent advances in cancer nanotechnology have raised exciting opportunities for specific drug delivery by an emerging class of nanotherapeutics that may be targeted to neoplastic cells, thereby offering a major advantage over conventional chemotherapeutic agents. There are two ways by which targeting of nanoparticles may be achieved, namely passive and active targeting. The aim of this study was to provide a comprehensive review of the literature focusing on passive targeting.
View References

Related Articles

Journal Cover

November 2014
Volume 2 Issue 6

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Bazak, R., Houri, M., El Achy, S., Hussein, W., & Refaat, T. (2014). Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. Molecular and Clinical Oncology, 2, 904-908. https://doi.org/10.3892/mco.2014.356
MLA
Bazak, R., Houri, M., El Achy, S., Hussein, W., Refaat, T."Passive targeting of nanoparticles to cancer: A comprehensive review of the literature". Molecular and Clinical Oncology 2.6 (2014): 904-908.
Chicago
Bazak, R., Houri, M., El Achy, S., Hussein, W., Refaat, T."Passive targeting of nanoparticles to cancer: A comprehensive review of the literature". Molecular and Clinical Oncology 2, no. 6 (2014): 904-908. https://doi.org/10.3892/mco.2014.356